Capital Performance Advisors LLP Harmony Biosciences Holdings, Inc. Transaction History
Capital Performance Advisors LLP
- $325 Million
- Q3 2024
A detailed history of Capital Performance Advisors LLP transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Capital Performance Advisors LLP holds 84 shares of HRMY stock, worth $2,778. This represents 0.0% of its overall portfolio holdings.
Number of Shares
84Holding current value
$2,778% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HRMY
# of Institutions
227Shares Held
45.1MCall Options Held
48.2KPut Options Held
56.5K-
Valor Management LLC Chicago, IL11.2MShares$371 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$193 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.52MShares$116 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$86.2 Million11.62% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.51MShares$83 Million0.19% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.96B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...